A new study reveals a critical vulnerability in a brain receptor targeted by a rare autoimmune disease. Researchers have ...

Glaucoma has long been treated as a plumbing problem of the eye, managed mainly by lowering pressure rather than protecting ...

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...

Explore how claudin-18.2 can transform cancer treatment for gastric and pancreatic tumours using targeted radiotherapy.

The FDA has granted priority review to the new drug application (NDA) for gedatolisib, a first-in-class multi-target ...

OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round. The Company ...

One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, according to a new study published November 5, 2025, in npj Precision Oncology ...

Human history was forever changed with the discovery of antibiotics in 1928. Infectious diseases such as pneumonia, tuberculosis and sepsis were widespread and lethal until antibiotics made them ...